| Medical and Health Sciences | 2021-2025 | 752 | US 260 | 99.83 |
| Hematology | Lifetime | 54 | US 34 | 99.70 |
| Medical Genetics | Lifetime | 138 | US 74 | 98.99 |
| Pathology and Forensic Medicine | Lifetime | 452 | US 209 | 98.13 |
| Oncology | Lifetime | 748 | US 417 | 98.45 |
| Hematology | 2021-2025 | 23 | US 12 | 99.60 |
| Oncology | 2021-2025 | 444 | US 198 | 94.61 |
| Medical Genetics | 2021-2025 | 326 | US 150 | 78.99 |
| Multiple Myeloma Research and Treatments | Lifetime | 37 | US 21 | 99.74 |
| Peptidase Inhibition and Analysis | Lifetime | 99 | US 46 | 99.50 |
| Protein Degradation and Inhibitors | Lifetime | 39 | US 21 | 99.60 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 125 | US 70 | 99.59 |
| Lymphoma Diagnosis and Treatment | Lifetime | 172 | US 83 | 99.44 |
| Cancer Treatment and Pharmacology | Lifetime | 205 | US 113 | 99.37 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 72 | US 44 | 98.83 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 105 | US 53 | 99.08 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 229 | US 102 | 98.81 |
| Viral-associated cancers and disorders | Lifetime | 253 | US 124 | 98.47 |
| Cancer Mechanisms and Therapy | Lifetime | 175 | US 89 | 98.10 |
| Hematological disorders and diagnostics | Lifetime | 212 | US 104 | 96.89 |
| Multiple and Secondary Primary Cancers | Lifetime | 784 | US 340 | 92.95 |
| Chemokine receptors and signaling | Lifetime | 992 | US 372 | 89.28 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 31 | US 12 | 99.60 |
| Protein Degradation and Inhibitors | 2021-2025 | 40 | US 18 | 99.13 |
| CAR-T cell therapy research | 2021-2025 | 433 | US 242 | 97.27 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 264 | US 90 | 95.44 |
| Cancer Treatment and Pharmacology | 2021-2025 | 195 | US 65 | 96.12 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 486 | US 216 | 95.17 |
| Peptidase Inhibition and Analysis | 2021-2025 | 577 | US 140 | 90.50 |
| Cancer Mechanisms and Therapy | 2021-2025 | 241 | US 33 | 87.83 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 430 | US 197 | 90.70 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 922 | US 299 | 75.99 |
| Hematological disorders and diagnostics | 2021-2025 | 463 | US 126 | 64.77 |
| Chemokine receptors and signaling | 2021-2025 | 634 | US 125 | 57.35 |
| Garlic and Onion Studies | 2021-2025 | 847 | US 43 | 44.81 |
